Hanna Irie

Dr. Irie is Assistant Professor of Medicine and Oncological Sciences at the Tisch Cancer Institute and Dubin Breast Center of Icahn School of Medicine at Mount Sinai in New York City. She received her MD and PhD degrees from Harvard Medical School and completed a residency in Internal Medicine at Massachusetts General Hospital, followed by a clinical fellowship in Hematology and Medical Oncology at the Dana-Farber Cancer Institute.

As a medical oncologist, she specializes in the treatment of patients with breast cancer, with a special focus on improving care for patients with triple-negative cancers for whom current treatment options are limited. In addition to patient care, she directs a lab-based translational breast cancer research program. The challenges faced by many of her patients drive the focus of the program's research. Her laboratory focuses on identifying novel therapeutic targets for breast cancer, particularly for treatment-resistant breast cancers, and understanding the mechanisms by which these candidate genes regulate breast tumor cell behavior. They are also developing models that more accurately mirror treatment-resistant triple-negative cancers so that they can be used to validate more effective treatment strategies and support clinical studies.

Education

• MD,PHD, Harvard Medical School
• BA, Harvard University
• Clinical Fellow, Dana-Farber Cancer Institute
• Instructor, Dana-Farber Cancer Institute/Harvard Medical School
• Intern/Resident, Massachusetts General Hospital
• MD, Harvard Medical School
• PhD, Harvard Medical School
• Research Fellow, Harvard Medical School
• Residency, Internal Medicine Massachusetts General Hospital
• Fellowship, Hematology-Oncology Dana Farber Cancer Institute